The number of people with susceptibility test result for rifampicin in Pakistan
Pakistan: The number of people with susceptibility test result for rifampicin was 125,823 in 2021. ▲ Rising
Latest (2021)
125,823
Change on year
up 73.0%
World rank
4th
of 155 countries
All-time high
125,823
in 2021
All-time low
36,136
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Pakistan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Pakistan stood at 125,823. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 73.0% on the previous year and up 248.2% over five years.
That places Pakistan 4th out of 155 countries with data for 2021, putting it in the top 10%.
The number of people with susceptibility test result for rifampicin in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 36,136 | — |
| 2018 | 57,791 | +59.9% |
| 2019 | 71,841 | +24.3% |
| 2020 | 72,718 | +1.2% |
| 2021 | 125,823 | +73.0% |
Pakistan compared with similar countries
- Pakistan's 125,823 is above the median for lower middle income countries, which is 2,804, 44.9× the median. (32 countries reporting)
- Pakistan's 125,823 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 309.9× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 55,256 | 36,136 | 71,841 | 3 |
| 2020s | 99,270 | 72,718 | 125,823 | 2 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 944.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 55,286 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Pakistan?
- The number of people with susceptibility test result for rifampicin in Pakistan was 125,823 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Pakistan?
- The highest recorded value was 125,823 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Pakistan?
- The lowest recorded value was 36,136 in 2017.
- How does Pakistan rank for the number of people with susceptibility test result for rifampicin?
- Pakistan ranks 4th out of 155 countries with data for 2021.
- Where does this Pakistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).